首页> 外文期刊>Microchemical Journal: Devoted to the Application of Microtechniques in all Branches of Science >New approach for simultaneous analysis of commonly used antigout drugs by HPLC/UV method; Application in pharmaceutical and biological analysis
【24h】

New approach for simultaneous analysis of commonly used antigout drugs by HPLC/UV method; Application in pharmaceutical and biological analysis

机译:HPLC / UV法同时分析常用抗原药物的新方法; 在制药和生物分析中的应用

获取原文
获取原文并翻译 | 示例
       

摘要

An innovative, simple, fast, specific and sensitive high performance liquid chromatographic method with ultraviolet detection (HPLC/UV) was established and validated for simultaneous determination of a combination of three commonly prescribed antigout drugs namely; Colchicine (CLN), Probenecid (PRD) and Febuxostat (FBX) in dosage forms and in human urine samples. GraceSmart RP C-18 column was utilized for separation of the studied mixture using isocratic mode of mobile system consisting of acetonitrile: water (55: 45, v/v; containing 0.5% v/v formic acid). Flow rate and detection wavelengths programming were designed to obtain a rapid and efficient separation. The cited drugs were separated within < 9 min. The retention times (t(g)) were 3.597, 5.357 and 8.250 for CLN, PRD and FBX; respectively. The linearity range for all the investigated drugs was 0.040 50.0 mu g/mL with detection limits of 1.94-6.48 mu g/mL. Additionally, the developed method was validated according to ICH and US-FDA guidelines and was successfully applied for simultaneous estimation of the studied drugs in their pure form, and in laboratory-made mixture solution of their respective tablets. The proposed method was also used for analysis of CLN and PRD in their combined tablets and in human urine samples obtained from healthy volunteers with good recoveries (98.39-101.87%). Furthermore, the stability of CLN-PRD mixture in urine samples was studied. In conclusion, this method is suitable for quality control purposes for simultaneous analysis of these co-administered antigout drugs in their binary and ternary mixtures.
机译:建立并验证了具有紫外检测(HPLC / UV)的创新,简单,快速,敏感的高性能液相色谱法,同时测定三种常见规定的抗原药物的组合;血氯氨酸(CLN),丙烯酸(PRD)和Febuxostat(FBX)以剂型和人尿样品。 GRACESMART RP C-18柱用于使用由乙腈:水(55:45,含有0.5%v / v甲酸)组成的移动系统的等物体模式进行研究的混合物。流速和检测波长编程被设计为获得快速有效的分离。将引用的药物分开在<9分钟内。保留时间(T(g))为CLN,PRD和FBX的3.597,5.357和8.250;分别。所有研究药物的线性范围为0.04050.0μg/ ml,检测限为1.94-6.48μg/ ml。此外,根据ICH和US-FDA指南验证了开发方法,并成功地应用于其纯形式的研究药物,并在实验室制成的它们各自的片剂溶液中进行估计。该方法还用于分析其组合片中的ClN和PRD,并从具有良好回收率的健康志愿者获得的人尿样(98.39-101.87%)。此外,研究了尿液中ClN-PRD混合物的稳定性。总之,该方法适用于质量控制目的,以便同时分析其二元和三元混合物中这些共同施用的抗原药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号